NexImmune

-$1.72 (-9.71%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NexImmune and other stocks, options, and ETFs commission-free!

About NEXI

NexImmune, Inc. engages in the development of novel approach to immunotheraphy designed to create therapies with curative potential for patients with cancer and other life threatening immune-mediated diseases. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.

CEO
Scott Carmer
Employees
44
Headquarters
Gaithersburg, Maryland
Founded
2011

NEXI Key Statistics

Market Cap
380.02M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
41.83K
High Today
$17.49
Low Today
$16.00
Open Price
$17.20
Volume
116.77K
52 Week High
$28.00
52 Week Low
$16.00

NEXI Earnings

-$0.71
-$0.47
-$0.24
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 16, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure